Click here for list of all abbreviations

TOPIC

Definition

CPAP is continuous positive airway pressure. It is used via a tight fitting facial appliance ("face mask") to treat obstructive sleep apnea, plus some acute medical problems in hospitalized patients (see Principal Indications, below). With CPAP the patient is exposed to an airway pressure above the ambient or room air pressure, which is always referenced to zero. Thus a CPAP of 5 cm H2O means the patient is continually breathing against an airway pressure 5 cm H2O above the ambient or 'zero' pressure. The pressure curve (see below) looks the same as if breathing at ambient pressure, so that inspiratory and expiratory pressure are still below and above the baseline, respectively. Because the pressue is set at some specific level above ambient (usually in the range of 5 to 15 cm H2O) CPAP can be thought of as 'uni-level' positive airway pressure (though it is never called that), to distinguish it from bilevel positive airway pressure or BiPAP.

BiPAP is bilevel positive airway pressure. It is also used to treat sleep apnea patients, as well as some acute medical problems in hospitalized patients (see Principal Indications, below). The same types of facial appliance ("face mask") used for CPAP are also used for BiPAP. Whereas CPAP sets a single pressure above the ambient pressure, BiPAP sets two pressures above the ambient, a higher (IPAP) and a lower (EPAP), e.g., 10/5 cm H2O (see pressure curve, below). In BiPAP the higher pressure is experienced on inspiration and the lower pressure on expiration. Note that both pressures are always above ambient.

NOTE: This table compares CPAP, BiPAP and ASV. For a more detailed discussion of ASV, including comparison of the devices manufactured by ResMed and Respironics, Click here.

ASV stands for adaptive servo ventilation. The devices that deliver ASV are currently available from only two companies: ResMed Corporation and Philips Respironics. ASV is for patients with sleep apnea conditions that don't respond to CPAP or BiPAP. Rather than making the patient breathe against a fixed pressure, ASV actually monitors how much air the patient is exhaling, and adjusts the next breath accordingly, to give enough pressure to treat the sleep apnea. Adaptive Servo Ventilation (ASV):
a) is relatively new, widely available only in the last few years;
b) is applicable to only a small subset of sleep apnea patients, those with central sleep apnea and complex sleep apnea (situation where central apneas appear during CPAP titration);
c) has no direct counterpart for intubated patients (as do CPAP and BiPAP); and
d) is a proprietary mode, offered at this time by only the two companies. Note that the term "ASV" itself is a trademark of ResMed, but as a mode of ventilation is also offered by Respironics, which calls its machine "autoSV". (See Confusing Points Clarified, below).

Pressure Curve Examples

Top: Normal pressure curve (pressure measured at the mouth level) breathing at ambient ("0") pressure; airway pressure is @ -3 cm H2O at peak of inspiration (I) and @ +3 cm H2O at peak of expiration (E).
Bottom: Pressure curve when CPAP = 5 cm H2O; the baseline pressure against which the patient breathes is raised 5 cm H2O above ambient. I = peak of inspiration, E = peak of expiration.

NOTE: CPAP can also be delivered to the intubated patient.

Pressure curve when BiPAP = 10/5 cm H2O; now the pressure is higher on inspiration than on expiration, but both pressures are above ambient. Note that 'I' and 'E' in the normal breathing and CPAP pressure curves are replaced here by "IPAP" (inspiratory positive airway pressure) and "EPAP" (expiratory positive airway pressure). That's because with BiPAP (and ASV) the pressures are set by the machine (based on the doctor's orders). In this example IPAP is set as 10 cm H2O and EPAP is set as 5 cm H2O.

NOTE: BiPAP is equivalent to PSV (pressure support ventilation) + PEEP (positive end-expiratory pressure) in the intubated patient; in that situation PEEP is the same as EPAP.

ASV is BiPAP with a twist. The IPAP and EPAP can vary, depending on the patient's needs. In some ASV-type machines the EPAP is fixed and only the IPAP changes; in others both can change. Basically, in ASV one or both pressures is continously adjusted, so that the ventilation delivered to the patient 'adapts' to the situation.

ASV pressure curve in a polysomnogram
Click here for full size image, then back space to return to table.

Figure is from Banno K, Okamura K, Kryger MH: Adaptive Servo-Ventilation in patients with idiopathic Cheyne-Stokes breathing. J Clinical Sleep Medicine 2006; Vol 2, pages 181-186.

History

CPAP was developed in 1981 by Professor Colin Sullivan (Royal Prince Alfred Hospital in Sydney, Australia) for treating patients with severe sleep apnea. This seminal work was first published in Lancet (Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862-5.). Dr. Sullivan essentially reversed a vacuum cleaner motor so it would blow air into a patient's nose via via tubing. As expected, this kept the airway from collapsing. Within a few years CPAP was commercially available in the U.S., and replaced tracheostomy as treatment of choice for severe OSA. Without doubt CPAP was the catalyst for widespread development of sleep labs to diagnose OSA and for the evolution of sleep medicine as a recognized medical specialty.

BiPAP was developed in mid 1990's by Respironics Corporation, trademarked 'BiPAP'. Since BiPAP is a trademark, other companies use different terms, such as 'bilevel', VPAP (variable positive airway pressure), and "duo." One internet ad shows 4 different bilevel machines from 4 different manufacturers; only Respironics' machine is "BiPAP."

At some point in the late 1990s ResMed Corporation developed an ASV machine, and had it tested in heart failure patients with Cheyne-Stokes respiration. C-S respiration, a waxing and waning resipratory rate with periods of apnea, often occurs during sleep in patients with congestive heart failure. The first clinical article to appear on ASV was Teschler H, et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001;164:614-9.

Over the next decade more articles appeared showing that ASV could treat not only Cheyne-Stokes respiration, but a syndrome that wasn't even recognized in 2001: Complex Sleep Apnea, which is the intrusion of central sleep apneas when some patients are treated for OSA with CPAP or BiPAP. For later reviews see:
Allam JS, et al. Efficacy of servoventilation in treatment of complex and central sleep apnea syndromes. Chest 2007 Dec;132:1839-46. and
Morgenthaler TI, et. al. Adaptive Servoventilation Versus Noninvasive Positive Pressure Ventilation for Central, Mixed, and Complex Sleep Apnea Syndromes. SLEEP, Vol. 30, No. 4, pages 468-475, 2007.

Principal Indications

(Discussed in more detail below under Acute Setting and Non-Acute Setting)

Non-acute setting: Treatment of obstructive sleep apnea.

Acute setting: Pulmonary edema or COPD exacerbation, when there is hypoxemia but not CO2 retention.

Note: CPAP by face mask = PEEP in the intubated patient.

Non-acute setting:
1) When CPAP doesn't work for sleep apnea. <
2) For patients with chronic CO2 retention who also have sleep apnea.
3) For patients with neuromuscular disease who need some assistance with nocturnal ventilation.

Acute setting: Pulmonary edema or COPD exacerbation, when there is CO2 retention and a desire to avoid endotracheal intubation.

Note: BiPAP by face mask = PSV + PEEP in the intubated patient.

Non-acute setting: 1) Central sleep apnea unresponsive to CPAP or BiPAP. 2) Complex sleep apnea.

Acute setting: Very rarely (see ACUTE SETTING, below).

How is the pressure applied non-invasively?

Via a tight fitting mask attached in such a way that air can be blown into the nose or the nose and mouth (see mask photos below). The mask connects to a hose that is attached to a CPAP machine

Same as with CPAP, but machine used is designed to deliver BiPAP.

Same as with CPAP but machine used is designed to deliver ASV.

What kind of mask is used?

The mask choices are the same whether the patient is using CPAP or BiPAP. Generally there are 3 types: nasal mask, nasal pillows, and full face mask. (See special situation for mask under ASV.)

(The nasal mask (left) and nasal pillows (right) can be used with CPAP or BiPAP.)

Same as for CPAP

(The full face mask shown can be used with CPAP, BiPAP or ASV.)

Same as for CPAP. However, ResMed specifies their brand of full face mask for the ResMed VPAP AdaptSV machine. See Typical Prescription, below.

Typical Prescription
(For use while sleeping; determined after a 'pressure titration study' in the sleep lab)

CPAP at 10 cm H2O via best-fit mask [nasal or other], with heated humidity

A typical CPAP machine. There are multiple machine manufacturers (ResMed, Respironics, Fisher & Paykil, DeVilbiss, Puritan Bennett, Viasys, etc.)

Click here for short youtube.com video showing the types of machines

BiPAP at 12/8 cm H2O via best-fit mask [nasal or other], with heated humidity.

In this prescription the higher number is IPAP (inspiratory positive airway pressure) and the lower number is EPAP (expiratory positive airway pressure)

A typical BiPAP machine. There are multiple machine manufacturers (ResMed, Respironics, Fisher & Paykil, DeVilbiss, Puritan Bennett, Viasys, etc.)

ResMed VPAP Adapt SV: EPAP [expiratory positive airway pressure] = 7.0 cm H2O, Minimum PS [pressure support] = 4.0 cm H2O, Maximum PS = 13.0 cm H2O, via ResMed Quattro Full Face Mask (mask recommended by ResMed with this machine), with heated humidity. Below is the ResMed ASV machine.

OR

Respironics autoSV: EPAP [expiratory positive airway pressure] = 7.0 cm H2O, Minimum PS [pressure support] = 4.0 cm H2O, Maximum PS = 13.0 cm H2O. Respironics states their machine can be used with virtually any mask. Below is the Respironics autoSV machine.

Note: Respironics has an upgraded version of autoSV, called autoSV Advanced. The auto SV Advanced machine allows the EPAP to vary along with the PS (pressure support) level. In the autoSV you would set a lower and higher EPAP, e.g., EPAP-min = 7, EPAP-max = 12.

Click here for a more detailed comparison of the two companies' ASV devices.

Medicare Coverage Guidelines

1. Face-to-face clinical evaluation by treating physician prior to sleep study
2. Medicare-covered sleep test that shows AHI (apnea+hypopnea index) or RDI (respiratory disturbance index) 15 event/hr. or higher, or
AHI or RDI 5-14 events/hr. with documentation of excessive daytime sleepiness, impaired cognition, mood disorders or insomnia or hypertension, ischemic heart disease, or history of stroke.

(Note that there are additional criteria for continued coverage, including a face-to-face evaluation between the 31st and 90th day of treatment.)

Same criteria for CPAP (face-to-face evaluation, specified AHI/RDI level) and CPAP has been tried and proven ineffective

(Note that there are additional criteria for continued coverage, including a face-to-face evaluation between the 31st and 90th day of treatment.)

The following information is from the CMS web site on Respiratory Assist Devices

for Central sleep apnea, defined as:
1. Study showing AHI > 5 events/hr. and
2. Central apneas/hypopneas greater than > 50% of the total apneas/hypopneas, and
3. Central apneas or hypopneas >=5/hr., and
4. Symptoms of either excessive sleepiness or disrupted sleep.

for Complex sleep apnea
CompSA is a form of central sleep apnea specifically identified by the persistence or emergence of central apneas or hypopneas upon exposure to CPAP or an EO470 [Bi-level] device when obstructive events have disappeared. These patients have predominantly obstructive or mixed apenas during the diagnostic sleep study occurring at >= 5 times per hour. With use of a CPAP or EO470 [Bi-level], they show a pattern of apneas and hypopneas that meets the definition of CSA described above.

[NOTE: CMS defines an hypopnea as "an abnormal respiratory event lasting at least 10 seconds associated with at least a 30% reduction in thoracoabdominal movement or airflow as compared to baseline, and with at least a 4% decrease in oxygen saturaiton." This definition makes the CMS criteria for central sleep apnea and CompSA confusing, because hypopneas are not traditionally scored as obstructive or central, but simply 'hypopneas'. Thus by CMS criteria a patient could have persistently high AHI from obstructive hypopneas after a CPAP/BiPAP titration, yet qualify for an ASV machine. One doubts that was the intent of the stated criteria.]

Confusing Points Clarified

CPAP is often discussed under the general subject of non-invasive ventilation but CPAP does not, technically, provide 'ventilation' to the patient. It sets a single higher ambient pressure against which the patient breathes, but does not (or is not designed to) augment alveolar ventilation. Thus if your goal is to improve someone's PaCO2 non-invasively (i.e, to treat hypercapnia), CPAP is not the method of choice; instead, BiPAP is recommended.

Another clarification about CPAP is that it is a generic term, not any manufacturer's trademark, like BiPAP and ASV. It is offered on machines from multiple companies, all of whom may use the term 'CPAP'. (See 'Typical Prescription', above.)

Manufacturers may embellish their CPAP with little twists which are patented, and seldom adequately explained. An example is Respironics' CFlex and CFlex+. They are 'pressure relief' modes that abruptly drop the pressure in the transition from inspiration to expiration, to a sharper degree than would occur with passive exhalation. The mode is designed to make CPAP more comfortable for the patient and improve overall compliance (Nilius et al, 2006 and Dolan et al, 2009). CFlex comes in 3 levels, 1, 2 and 3, representing roughly 1, 2 or 3 cm H2O drop in pressure. CFlex+ is supposed to be an advance over regular CFlex.

Finally, 'CPAP' is mis-used for a ventilator mode on the Puritan-Bennett 7200 ventilator, as shown in the bottom row of the PB-7200 panel (3rd from left).

The 'CPAP' mode on the 7200 is for the spontaneously breathing patient, who may or may not be receiving CPAP. Thus the CPAP mode on the 7200 can allow for CPAP, PSV (pressure support ventilation), PSV with PEEP (same as BiPAP) or simply normal breathing with no increase in airway pressures (though the patient is still intubated).

BiPAP is used for non-invasive ventilation. It is designed to augment alveolar ventilation because it delivers two pressures, one higher (IPAP or inspiratory positive airway pressure) and one lower (EPAP, or expiratory positive airway pressure); however, both IPAP and EPAP are above ambient presure. BiPAP is the same as PSV + PEEP in the intubated patient.

BiPAP is actually a trademark of Philips Respironics, and so cannot be used in advertising by other manufacturers. ResMed Corporation, for example, uses the term "Bilevel" instead of BiPAP. Many machines are on the market that can deliver BiPAP (see 'Typical Prescription' above).

Also confusing is that BiPAP comes in several 'modes' -- all variations on the simple two pressure model:

• S (Spontaneous) Mode. The device triggers IPAP when flow sensors detect spontaneous inspiratory effort and then cycles back to EPAP.
• T (Timed) Mode. Here the IPAP/EPAP cycling is purely machine-triggered, at a set rate, typically expressed in breaths per minute.
• S/T (Spontaneous/Timed) Mode. Here the machine triggers to IPAP on patient's inspiratory effort, but there is also a 'backup" rate. This rate is set to ensure that patients still receive a minimum number of breaths per minute if they fail to breathe spontaneously. However, this is not a ventilator mode and will not provide life support for the continously apneic patient.

Respironics also has a BiPAP machine designed specifically for patients with hypoventilation disorders (e.g., restrictive thoracic disorders, obesity hypoventilation syndrome, some cases of central apnea and COPD). It is called BiPAP AVAPS. AVAPS stands for "Average Volume Assured Pressure Support," and is basically a mode for giving non-invasive ventilation to patients with hypoventilation. Not to be confused with ASV (see next column), AVAPS is not for complex sleep apnea or sleep apnea unresponsive to CPAP and BiPAP (which are the indications for ASV). This type of device, while theoretically important in a niche market, does in fact overlap with regular BiPAP and ASV, and so can confuse the overall picture of positive pressure devices (see Recommendation, below).

While BiPAP is generally better than CPAP for patients with CO2 retention, or who need augmentation in alveolar ventilation, there is no rule of thumb about which BiPAP mode is 'best'. That can only be determined with a careful titration of pressures in the hospital or sleep lab.

ASV is a CONFUSING term, for several reasons.

1) It is a manufacturers' proprietary trademark, owned by ResMed Corporation. ResMed was the first company to come out with this type of 'smart' machine, which is designed (and Medicare-approved) for treatment of central sleep apnea and complex sleep apnea.

2) Another equipment company, Philips Respironics, has come out with a competing machine for the same set of conditions. Respironics calls its machine BiPAP-autoSV, which stands for 'automatic servo ventilation.' Obviously this is also 'ASV' but Respironics can't market their machine as 'ASV' and they always use the term "autoSV".

3) The algorithms that govern these machines are both proprietary, which means they can't be duplicated by any other machines on the market.

4) The manufacturers use a variety of abbreviations, often without explanation, in their brochures and web sites. Sometimes they use "EEP" (end-expiratory pressure) to indicate what is more commonly called "EPAP" (expiratory positive airway pressure), and "PS" (pressure support) to indicate "IPAP" (inspiratory positive airway pressure). At other times they will use EPAP, IPAPmin, IPAPmax. EPAPmin and EPAPmax. When you add this variety of pressure abbreviations to 'ASV', 'autoSV', VPAP, etc., the result is often a mishmash of confusing lingo. I have yet to see a brochure or web site that lists all the abbreviations alongside equivalent terms and full text explanations. (The companies have great engineers but need better writers.)

5) Though ASV is a proprietary term, being first on the market, it is now used generically to mean 'a machine that is designed to treat central or complex sleep apnea'. Thus if you send a patient to the sleep lab for 'titration with ASV', and the lab has only the Respironics autoSV, that machine will likely be used for the pressure titration. You will get a report of ASV titration with Auto-SV. (An analogy is "Band-Aid", which is a trademarked term by Johnson & Johnson but used by everyone to mean a small tape bandage sold in stores.)

In summary, ASV-type machines are an evolving technology, and the terminology is not as well defined as it is with BiPAP and CPAP.

Unless specifically stated otherwise, ASV in this web site can be inferred to mean ResMed's or Respironics' ASV devices. Click here for a table comparing the two companies' ASV devices.

What are the principal uses in the ACUTE SETTING?

In the ACUTE SETTING, CPAP is used for patients with low oxygen saturation in whom O2 at ambient pressure (nasal cannula, loose fitting face mask) is not sufficient. The increased ambient pressure provided by CPAP 'recruits' or opens up more alveoli, allowing supplemental oxygen to better oxygenate the blood. Conditions commonly treated with CPAP in the ACUTE SETTING include pulmonary edema (cardiac and non-cardiac) and COPD exacerbation. If the condition doesn't improve and CPAP is not effective, generally the next step is intubation and mechanical ventilation.

There are three broad criteria for CPAP in the ACUTE SETTING:

1) The patient must have a dangerously low SaO2 that cannot be corrected with supplemental oxygen delivered high-flow, loose-fitting mask.
2) The patient must be alert; CPAP should not be applied to a patient with impaired mental status because of risk of aspiration (such patients need to be intubated);
3) The crisis must be perceived as of short duration, as CPAP is impractical long term. "Short duration" is arbitrary, but generally if the patient is awake and the problem (e.g., pulmonary edema) is likely to get better with treatment in a few hours, CPAP may be a good idea to help avoid intubation. If the condition is unlikely to get better quickly, then intubation is preferred as that is more stable long term.

Click here for introductory lecture on youtube.com of CPAP

In the ACUTE SETTING, BiPAP is used for patients with high PaCO2 (hypercapnea) when it is causing either respiratory acidosis and/or hypoxemia, and the sitaution is expected to stabilize with medical therapy. The most common condition treated with BiPAP in the ACUTE SETTING is COPD exacerbation. However, any other condition that may lead to hypercapnea can also be treated with BiPAP. Generally, if the condition doesn't improve and BiPAP is not effective, the next step is intubation and mechanical ventilation.

As with CPAP, there are 3 broad criteria for BiPAP in the ACUTE SETTING:

1) the patient mush have dangerously high PaCO2 that the physician feels should be lowered as quickly as possible, without endotracheal intubation;
2) the patient must be alert
3) the crisis must be perceived as of short duration, as BiPAP is impractical long term. As with CPAP, this is arbitrary, but generally if the patient is awake and the crisis (e.g., COPD exacerbation) is likely to get better with treatment in a few hours, BiPAP may be a good idea. If the condition is unlikely to get better quickly, then intubation is preferred as that is more stable long term.

Click here for introductory lecture on youtube.com of BiPAP

ASV via face mask is not used in the acute setting. ASV as a ventilatory mode in intubated patients is used occasionally. One study (Intensive Care Med. 2010 Aug;36(8):1371-9. Epub 2010 May 26. Adaptive support ventilation versus conventional ventilation for total ventilatory support in acute respiratory failure. Iotti GA, et. al.) found that "Comparison between ASV and CV [controlled ventilation] resulted either in similarities or in minor differences. Except for excessive Vt in a few obstructed patients, all differences were in favor of ASV."

What are the principal uses in the NON-ACUTE SETTING?

In the NON-ACUTE SETTING, CPAP is used almost exclusively for obstructive sleep apnea (OSA). There are degrees of severity for OSA, but generally the more severe the condition, the more likely CPAP will be prescribed and the more efficacious it will be for the patient. Note that CPAP is generally not helpful in patients with central sleep apnea (CSA). For CSA, BiPAP or ASV are indicated.

In the NON-ACUTE SETTING, BiPAP has 3 main uses:

1) For obstructive sleep apnea (OSA) that does not respond to CPAP. Either there is patient intolerance to the fixed pressure, or the patient just needs two levels of pressure to eliminate the apneas. In these situations BiPAP is often effective.

2) BiPAP is generally more effective than CPAP in central sleep apnea (e.g., Cheyne-Stokes breathing).

3) BiPAP is sometimes used for patients with chronic hypercapnia, for augmentation of oxygenation and ventilation during sleep. Examples include patients with neuromuscular impairment (post-polio syndrome; amyotrophic lateral sclerosis).

Click here for brief introductory youtube.com video about BiPAP

ASV is currently used almost exclusively in the NON-ACUTE SETTING setting, for patients with 'complex sleep apnea'. CompSA, as it's abbreviated, is defined as central sleep apnea that appears when obstructive sleep apnea is treated with CPAP or BiPAP. Thus, ASV is indicated for situations when CPAP or BiPAP has failed. Even so, it remains somewhat unsettled about when ASV should be used, how effective it is, and how to follow up such patients.

What is the cost in the non-acute setting?

It depends on who is paying. There is no meaningful way to make cost comparisons, because patients rarely pay out of pocket for these machines. The cost is paid by either Medicare, Medicaid or commercial insurance companies. There are many web sites for purchasing these machines, such as cpap.com, CPAP-Supply and The CPAP Shop.

At cpap.com you will find prices ranging from @$200 for a basic CPAP machine to $5800 for 'smart' or ASV-type machines (not counting mask, which is extra). In clinical practice patients usually get their machine from a a DME (durable medical equipment) company, whose cost is higher than on the internet because they provide service to the machines and training to the patient. Even so, DME companies will generally accept whatever the insurer pays, as long as it covers their cost. The insurer will sometimes rent the machine from the DME company, sometimes buy it outright, and there may or may not be a deductible to the patient. Thus there is no simple answer.

Note that the equipment costs DO NOT include the cost of the sleep study needed to make the diagnosis, or the physician's professional fees. In a typical scenario (one or two nights in a sleep lab, professional fees, all equipment) the total cost to diagnose and treat sleep apnea with a basic CPAP device is likely around $4000 - $5000. Since this is a non-recurring charge, and can in the long run prevent many costly and serious medical problems for the patient, insurers routinely cover most or all of the costs.

See comments under CPAP.

Same comments under CPAP.

Recommendation: ONE machine for all

In the last decade there has been explosive growth in the field of sleep medicine and positive pressure devices used to treat patients with OSA, CSA and ComplexSA. Machines have become smaller and quieter, which is a good thing. They have to some extent also become commoditized, and are available for sale on numerous web sites, including ebay. At the same time the manufacturers have introduced a plethora of 'machine types' which keep prices for the newer machines high and serve to confuse the consumer. In this case the consumer is both the patient AND the physician who must write the prescription. Consider this current line up of positive pressure devices for patients with sleep disorders from just one company, Respironics.

• CPAP REMstar Plus with CFlex - 4 different model numbers - used for obstructive sleep apnea (OSA)
• CPAP REMstar Auto with AFlex - 2 different model nos. - for OSA
• BiPAP Pro with BiFlex - 2 different model nos. - for OSA patients not responsive to CPAP
• BiPAP Auto wtih BiFlex - 2 different model nos. - for OSA patients not responsive to CPAP
• BiPAP auto SV Advanced - 2 different model nos. - for central sleep apnea and complex sleep apnea
• BiPAP AVAPS - 4 different model numbers - for patients with hypoventilation

These 6 different machines all work the same, delivering postive pressure from a small box. The differences reside in the algorithms used to deliver the pressures. They could all be in one machine. This is the situation with a hospital ventilator, as used in the ICU: one machine that delivers any mode of ventilation the patient needs. Doctors don't keep changing the ventilator machine when the mode changes. ALL of the modes are built into one machine.

Is this feasible for the small machines used to treat patients with sleep apnea? Not only is it feasible, it exists! It's the lab version of the machines, the one used in the sleep lab to 'titrate' pressures to the level needed, depending on the situation It's called the OmniLab, a machine that has most of the modes built in. Respironics states "many therapy modes and Respironics' patented comfort technologies are available for titration of almost any patient type, including pediatric patients ages seven and older, in CPAP; BiPAP S, BiPAP S/T, T and PC modes." But the Omnilab is not sold for home use. There is no consumer version of the Omnilab.

We need ONE machine for patients with sleep disorders, with all modes built in. Not 6 different machines and over a dozen different models from just one company. The only valid objection is that the high tech machines cost more, and that the companies can't sell one machine at one price with a wide range of functions and still make a profit. This objection is easily overcome by charging for the program used, not the machine. Just as several people with the same identical cell phone can pay different rates depending on the service (phone calls only, internet access + phone, etc.) the charge could be based on the modality used: more for ASV and less for simple CPAP.

The sleep community needs an all purpose positive pressure machine that can do everything, whatever the clinical circumstance, and not this plethora of confusing, overlapping machines that are all too often poorly understood. Such an approach from industry might even sell more machines, especially if prices come down, and patients realize they can try different modalities while at home, without obsoleting their existing machine.

See comments under CPAP.

Same comments under CPAP.

ABBREVIATIONS (alphabetical order)
ASV - adaptive servo ventilation
autoSV - automatic servo ventilation
BiPAP - bilevel positive airway pressure
cm H2O - centimeters of water
COPD - chronic obstructive pulmonary disease
CPAP - continuous positive airway pressure
CSA - central sleep apnea
E - expiration or expiratory
EEP - end-expiratory pressure
EPAP - expiratory positive airway pressure
I - inspiration or inspiratory
IPAP -inspiratory positive airway pressure
max - maximum
min - minimum
NIV - non-invasive ventilation
OSA - obstructive sleep apnea
PEEP - positive end-expiratory pressure
PS - pressure support
PSV - pressure support ventilaton
S - spontaneous
S/T - spontaneous/timed
SV - servo ventilation
VPAP - variable positive airway pressure